These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3907492)

  • 1. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
    Leclercq R; Carlier C; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1985 Sep; 28(3):421-4. PubMed ID: 3907492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
    Barcs I
    J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025.
    Bozdogan B; Berrezouga L; Kuo MS; Yurek DA; Farley KA; Stockman BJ; Leclercq R
    Antimicrob Agents Chemother; 1999 Apr; 43(4):925-9. PubMed ID: 10103201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes.
    Brisson-Noël A; Delrieu P; Samain D; Courvalin P
    J Biol Chem; 1988 Nov; 263(31):15880-7. PubMed ID: 2846528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide sequence of gene linA encoding resistance to lincosamides in Staphylococcus haemolyticus.
    Brisson-Noël A; Courvalin P
    Gene; 1986; 43(3):247-53. PubMed ID: 3091456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36.
    Achard A; Villers C; Pichereau V; Leclercq R
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2716-9. PubMed ID: 15980341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp.
    Leclercq R; Brisson-Noël A; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1887-91. PubMed ID: 3439797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake of clindamycin and lincomycin.
    Easmon CS; Crane JP
    Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-encoded resistance to macrolides and lincosamides in Staphylococcus hyicus.
    Schwarz S; Wegener H; Blobel H
    J Appl Bacteriol; 1990 Dec; 69(6):845-9. PubMed ID: 2286583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Devriese LA
    Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanisms of resistance to lincosamides in Staphylococcus and Arthrobacter spp.
    Quiros LM; Fidalgo S; Mendez FJ; Hardisson C; Salas JA
    Antimicrob Agents Chemother; 1988 Apr; 32(4):420-5. PubMed ID: 3377455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to macrolides, lincosamides, streptogramins, and linezolid among members of the Staphylococcus sciuri group.
    Stepanović S; Martel A; Dakić I; Decostere A; Vuković D; Ranin L; Devriese LA; Haesebrouck F
    Microb Drug Resist; 2006; 12(2):115-20. PubMed ID: 16922627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance genes in coagulase-negative staphylococci isolated from food.
    Perreten V; Giampà N; Schuler-Schmid U; Teuber M
    Syst Appl Microbiol; 1998 Mar; 21(1):113-20. PubMed ID: 9741115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical microbiology of lincomycin antibiotics].
    Modde H
    Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
    [No Abstract]   [Full Text] [Related]  

  • 16. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
    Bassler M; Just HM; Richter A; Zeller H; Daschner F
    Infection; 1984; 12(4):280-5. PubMed ID: 6490174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of streptococcal plasmid-determined resistance to erythromycin and lincomycin in Escherichia coli.
    Malke H; Holm SE
    Mol Gen Genet; 1981; 184(2):283-5. PubMed ID: 7035838
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance plasmids for inducible macrolide-lincosamide resistance in Staphylococcus simulans and Staphylococcus epidermidis.
    Barcs I
    Acta Microbiol Hung; 1985; 32(3):241-8. PubMed ID: 4082898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.